Pterostilbene Acts through Metastasis-Associated Protein 1 to Inhibit Tumor Growth, Progression and Metastasis in Prostate Cancer

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Li, Kun ^a   Dias, Steven J ^a   Rimando, Agnes M ^b   Dhar, Swati ^a   Mizuno, Cassia S ^b   Penman, Alan D ^a   Lewin, Jack R ^c   Levenson, Anait S ^a,c  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b NATURAL PRODUCTS UTILIZATION RESEARCH UNIT   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIACETYL RESVERATROL; 4 (3,5 DIMETHOXYSTYRYL)ANILINE; METASTASIS ASSOCIATED PROTEIN 1; ONCOPROTEIN; PICEATANNOL; PLANT MEDICINAL PRODUCT; PROTEIN P53; PTEROSTILBENE; RESVERATROL; TRIACETYL RESVERATROL; TRIMETHOXY RESVERATROL; UNCLASSIFIED DRUG;

ACETYLATION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; BLUEBERRY; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DEACETYLATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; SYNTHESIS;

ACETYLATION; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DISEASE PROGRESSION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MALE; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MICE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; STILBENES; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84874574897     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057542     Document Type: Article

References (48)

1. Bavaresco L, (2003) Role of viticultural factors on stilbene concentrations of grapes and wine. Drugs Exp Clin Res 29: 181-187.
2. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, et al. (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24: 2783-2840.
3. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
4. Kuwajerwala N, Cifuentes E, Gautam S, Menon M, Barrack ER, et al. (2002) Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis. Cancer Res 62: 2488-2492.
5. Clement MV, Hirpara JL, Chawdhury SH, Pervaiz S, (1998) Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002.
6. Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM, (2004) Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer 109: 167-173.
7. Feldman I, Feldman GM, Mobarak C, Dunkelberg JC, Leslie KK (2007) Identification of proteins within the nuclear factor-kappa B transcriptional complex including estrogen receptor-alpha. Am J Obstet Gynecol 196: 394 e391-311; discussion 394 e311-393.
8. Banerjee S, Bueso-Ramos C, Aggarwal BB, (2002) Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 62: 4945-4954.
9. Brakenhielm E, Cao R, Cao Y, (2001) Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 15: 1798-1800.
10. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, et al. (2004) Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10: 2190-2202.
11. Kimura Y, Okuda H, (2001) Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. J Nutr 131: 1844-1849.
12. Kozuki Y, Miura Y, Yagasaki K, (2001) Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action. Cancer Lett 167: 151-156.
13. Kai L, Samuel SK, Levenson AS, (2010) Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. Int J Cancer 126: 1538-1548.
14. Jang KS, Paik SS, Chung H, Oh YH, Kong G, (2006) MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Sci 97: 374-379.
15. Hofer MD, Kuefer R, Varambally S, Li H, Ma J, et al. (2004) The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 64: 825-829.
16. Toh Y, Kuwano H, Mori M, Nicolson GL, Sugimachi K, (1999) Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer 79: 1723-1726.
17. Iguchi H, Imura G, Toh Y, Ogata Y, (2000) Expression of MTA1, a metastasis-associated gene with histone deacetylase activity in pancreatic cancer. Int J Oncol 16: 1211-1214.
18. Sasaki H, Moriyama S, Nakashima Y, Kobayashi Y, Yukiue H, et al. (2002) Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer 35: 149-154.
19. Kai L, Wang J, Ivanovic M, Chung YT, Laskin WB, et al. (2011) Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1). Prostate 71: 268-280.
20. Toh Y, Pencil SD, Nicolson GL, (1994) A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269: 22958-22963.
21. Xue Y, Wong J, Moreno GT, Young MK, Cote J, et al. (1998) NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell 2: 851-861.
22. Juan ME, Vinardell MP, Planas JM, (2002) The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 132: 257-260.
23. Asensi M, Medina I, Ortega A, Carretero J, Bano MC, et al. (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33: 387-398.
24. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, et al. (2002) Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 302: 369-373.
25. Kondratyuk TP, Park EJ, Marler LE, Ahn S, Yuan Y, et al. (2011) Resveratrol derivatives as promising chemopreventive agents with improved potency and selectivity. Mol Nutr Food Res 55: 1249-1265.
26. Rimando AM, Nagmani R, Feller DR, Yokoyama W, (2005) Pterostilbene, a new agonist for the peroxisome proliferator-activated receptor alpha-isoform, lowers plasma lipoproteins and cholesterol in hypercholesterolemic hamsters. J Agric Food Chem 53: 3403-3407.
27. Mizuno CS, Ma G, Khan S, Patny A, Avery MA, et al. (2008) Design, synthesis, biological evaluation and docking studies of pterostilbene analogs inside PPARalpha. Bioorg Med Chem 16: 3800-3808.
28. Xu L, Ding Y, Catalona WJ, Yang XJ, Anderson WF, et al. (2009) MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst 101: 1141-1155.
29. Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimoto CH, et al. (2008) Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 68: 2024-2032.
30. Yu N, Kozlowski JM, Park, II, Chen L, Zhang Q, et al. (2010) Overexpression of transforming growth factor beta1 in malignant prostate cells is partly caused by a runaway of TGF-beta1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-beta type I receptor. Urology 76: 1519 e1518-1513.
31. Douillet-Breuil AC, Jeandet P, Adrian M, Bessis R, (1999) Changes in the phytoalexin content of various Vitis spp. in response to ultraviolet C elicitation. J Agric Food Chem 47: 4456-4461.
32. Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR, (2004) Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J Agric Food Chem 52: 4713-4719.
33. Wang TT, Schoene NW, Kim YS, Mizuno CS, Rimando AM, (2010) Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Mol Nutr Food Res 54: 335-344.
34. Rimando AM, Cuendet M, Desmarchelier C, Mehta RG, Pezzuto JM, et al. (2002) Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem 50: 3453-3457.
35. Paul S, DeCastro AJ, Lee HJ, Smolarek AK, So JY, et al. (2010) Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis 31: 1272-1278.
36. Ferrer P, Asensi M, Segarra R, Ortega A, Benlloch M, et al. (2005) Association between pterostilbene and quercetin inhibits metastatic activity of B16 melanoma. Neoplasia 7: 37-47.
37. Mikstacka R, Przybylska D, Rimando AM, Baer-Dubowska W, (2007) Inhibition of human recombinant cytochromes P450 CYP1A1 and CYP1B1 by trans-resveratrol methyl ethers. Mol Nutr Food Res 51: 517-524.
38. Pan MH, Chang YH, Tsai ML, Lai CS, Ho SY, et al. (2008) Pterostilbene suppressed lipopolysaccharide-induced up-expression of iNOS and COX-2 in murine macrophages. J Agric Food Chem 56: 7502-7509.
39. Pan MH, Chiou YS, Chen WJ, Wang JM, Badmaev V, et al. (2009) Pterostilbene inhibited tumor invasion via suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Carcinogenesis 30: 1234-1242.
40. Tolomeo M, Grimaudo S, Di Cristina A, Roberti M, Pizzirani D, et al. (2005) Pterostilbene and 3′-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol 37: 1709-1726.
41. Chang J, Rimando A, Pallas M, Camins A, Porquet D, et al. (2012) Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease. Neurobiol Aging 33: 2062-2071.
42. Lin HS, Yue BD, Ho PC, (2009) Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed Chromatogr 23: 1308-1315.
43. McCormack D, McFadden D, (2012) Pterostilbene and cancer: current review. J Surg Res 173: e53-61.
44. Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL, (2011) Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 68: 593-601.
45. Remsberg CM, Yanez JA, Ohgami Y, Vega-Villa KR, Rimando AM, et al. (2008) Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother Res 22: 169-179.
46. Chiou YS, Tsai ML, Nagabhushanam K, Wang YJ, Wu CH, et al. (2011) Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway. J Agric Food Chem 59: 2725-2733.
47. Chakraborty A, Gupta N, Ghosh K, Roy P, (2010) In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupium. Toxicol In Vitro 24: 1215-1228.
48. Link A, Balaguer F, Goel A, (2010) Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 80: 1771-1792.